Literature DB >> 23670580

[Quality of postoperative pain therapy: evaluation of an established anesthesiology acute pain service].

V Kainzwaldner1, B Rachinger-Adam, T Mioc-Curic, T Wöhrle, L C Hinske, B Luchting, T Ewert, S C Azad.   

Abstract

BACKGROUND: Despite well-designed concepts of perioperative pain management, recent studies have revealed that a large number of patients still suffer from unacceptable pain after surgery. The purpose of this prospective evaluation was to critically analyze postoperative pain treatment provided by a routinely established, DIN certified acute pain service (APS) at the University Hospital Großhadern in Munich.
MATERIALS AND METHODS: A total of 1,000 consecutive patients received one of the following analgesic procedures: continuous epidural analgesia (EA, n = 401), continuous and patient-controlled epidural analgesia (PCEA, n = 305), intravenous patient-controlled analgesia with opioids (PCA, n = 169) or continuous peripheral nerve block (CPNB, n = 125). For EA and PCEA, ropivacaine 0.2 % and sufentanil 0.24 µg/ml were administered while peripheral regional analgesia was performed with infusion of ropivacaine 0.2 % only. Patients with PCEA were allowed a 3 mg bolus once per hour on demand. Standardized intravenous PCA was performed with piritramide 2.5 mg/ml, a bolus of 2.5 mg, a lock-out time of 15 min, a maximum of 25 mg/4 h and no background infusion. During the daily visits the APS assessed pain intensity at rest and during movement on a numerical rating scale from 0 (no pain) to 10 (maximum pain), acceptance of pain, satisfaction with the analgesic procedure, demand of additional non-opioid analgesics, the need for optimization including bolus applications and changes of the infusion rate or retraction of the epidural catheter. The duration of the procedures, side effects and complications were documented. The catheter insertion sites were inspected daily for redness and tenderness on palpation.
RESULTS: In general, epidural and peripheral regional analgesic techniques were superior in terms of postoperative analgesia to intravenous opioid PCA and were associated with fewer side effects, such as sedation, nausea, vomiting, obstipation and sensorimotor deficits. A subgroup analysis revealed that in major upper abdominal surgery, EA provided significantly better analgesia at rest and during movement than PCA. In lower abdominal surgery PCEA induced significantly better analgesia than both PCA and EA, especially during movement. Patient satisfaction was generally high and was best with PCEA (95 %) followed by CPNB (94 %), EA (91 %) and PCA (88 %). On the first postoperative day analgesic procedures had to be optimized (e.g. by bolus administration, retraction of catheters or changes to standardized PCA) in 23 % of EA patients, 10 % of PCEA patients, 6 % of PCA patients and 12 % of CPNB patients. Major complications, such as neuraxial hematoma, infections or respiratory depression were not observed.
CONCLUSIONS: As described in many prospective studies, this evaluation revealed that for postoperative pain control, regional anesthesia is superior to intravenous patient-controlled analgesia with strong opioids in terms of analgesia and side effects. In the setting of a well-organized acute pain service with frequent education and training of all members involved, postoperative pain management is safe and effective. However, regular re-evaluation of the defined and certified procedures is necessary.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23670580     DOI: 10.1007/s00101-013-2177-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  29 in total

1.  [The role of anesthesiology in fast track concepts in colonic surgery].

Authors:  M Hensel; W Schwenk; A Bloch; W Raue; S Stracke; T Volk; C von Heymann; J M Müller; W J Kox; C Spies
Journal:  Anaesthesist       Date:  2006-01       Impact factor: 1.041

2.  [Quality management in postoperative pain therapy].

Authors:  W Meissner; K Ullrich; S Zwacka; T Schreiber; K Reinhart
Journal:  Anaesthesist       Date:  2001-09       Impact factor: 1.041

3.  [Quality of postoperative pain therapy in Austria: national survey of all departments of anesthesiology].

Authors:  C Kinstner; R Likar; A Sandner-Kiesling; D Hutschala; W Pipam; B Gustorff
Journal:  Anaesthesist       Date:  2011-09-15       Impact factor: 1.041

Review 4.  [Spinal and epidural anesthesia in patients with hemorrhagic diathesis : decisions on the brink of minimum evidence?].

Authors:  J S Englbrecht; E M Pogatzki-Zahn; P Zahn
Journal:  Anaesthesist       Date:  2011-07-31       Impact factor: 1.041

5.  Benchmarking as a tool of continuous quality improvement in postoperative pain management.

Authors:  W Meissner; K Ullrich; S Zwacka
Journal:  Eur J Anaesthesiol       Date:  2006-02       Impact factor: 4.330

6.  Major complications of epidural analgesia after surgery: results of a six-year survey.

Authors:  I W Christie; S McCabe
Journal:  Anaesthesia       Date:  2007-04       Impact factor: 6.955

7.  Severe neurological complications after central neuraxial blockades in Sweden 1990-1999.

Authors:  Vibeke Moen; Nils Dahlgren; Lars Irestedt
Journal:  Anesthesiology       Date:  2004-10       Impact factor: 7.892

8.  [Life-threatening opioid overdose. Decoding the physician pin code of a patient-controlled anesthesia pump by patients].

Authors:  K Imhof; K Krall; H Gombotz
Journal:  Anaesthesist       Date:  2012-09       Impact factor: 1.041

9.  National survey of hospital patients.

Authors:  S Bruster; B Jarman; N Bosanquet; D Weston; R Erens; T L Delbanco
Journal:  BMJ       Date:  1994-12-10

Review 10.  Efficacy of postoperative epidural analgesia: a meta-analysis.

Authors:  Brian M Block; Spencer S Liu; Andrew J Rowlingson; Anne R Cowan; John A Cowan; Christopher L Wu
Journal:  JAMA       Date:  2003-11-12       Impact factor: 56.272

View more
  8 in total

Review 1.  [Update on preemptive analgesia : options and limits of preoperative pain therapy].

Authors:  R Sittl; D Irnich; P M Lang
Journal:  Anaesthesist       Date:  2013-10       Impact factor: 1.041

2.  [Piritramide versus oxycodone for patient-controlled intravenous analgesia. Opioid-induced side effects].

Authors:  H Sebastian
Journal:  Schmerz       Date:  2014-12       Impact factor: 1.107

3.  [Pre-existing pain as comorbidity in postoperative acute pain service].

Authors:  J Erlenwein; J Schlink; M Pfingsten; J Hinz; M Bauer; M Quintel; F Petzke
Journal:  Anaesthesist       Date:  2013-08-31       Impact factor: 1.041

4.  [Safety and monitoring of patient-controlled intravenous analgesia : Clinical practice in German hospitals].

Authors:  M I Emons; M Maring; U M Stamer; E Pogatzki-Zahn; F Petzke; J Erlenwein
Journal:  Anaesthesist       Date:  2020-12-29       Impact factor: 1.041

5.  Can consistent benchmarking within a standardized pain management concept decrease postoperative pain after total hip arthroplasty? A prospective cohort study including 367 patients.

Authors:  Achim Benditz; Felix Greimel; Patrick Auer; Florian Zeman; Antje Göttermann; Joachim Grifka; Winfried Meissner; Frederik von Kunow
Journal:  J Pain Res       Date:  2016-12-19       Impact factor: 3.133

6.  Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings.

Authors:  Harold Tabori; Christin Arnold; Anke Jaudszus; Hans-Joachim Mentzel; Diane M Renz; Steffen Reinsch; Michael Lorenz; Ruth Michl; Andrea Gerber; Thomas Lehmann; Jochen G Mainz
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

7.  Influence on number of top-ups after implementing patient controlled epidural analgesia: A cohort study.

Authors:  Ganapathy van Samkar; Henning Hermanns; Philipp Lirk; Markus W Hollmann; Markus F Stevens
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

8.  Acute pain services in India: A glimpse of the current scenario.

Authors:  Parmanand N Jain; Sumitra G Bakshi; Raghu S Thota
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.